Article info

Download PDFPDF
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index

Authors

  1. Correspondence to Milla Elvi Linnea Kuusisto, Department of Oncology and Radiotherapy, University of Oulu, Medical Research Center and Oulu University Hospital, Kajaanintie 50, Oulu 90220, Finland; milla.kuusisto{at}student.oulu.fi
View Full Text

Citation

Kuusisto MEL, Haapasaari K, Turpeenniemi-Hujanen T, et al
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index

Publication history

  • Received November 30, 2014
  • Revised March 12, 2015
  • Accepted March 18, 2015
  • First published May 2, 2015.
Online issue publication 
June 19, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.